Wybrane Publikacje
Development and validation of the HPLC method for quality control of radiolabelled DOTA-TATE and DOTA-TOC preparations.
Marcin Radzik, Justyna Pijarowska-Kruszyna, Antoni Jaroń, Michał Maurin, Clemens Decristoforo, Renata Mikołajczak, Piotr Garnuszek
Nuclear Medicine and Biology 93 (2021) 63–73
https://doi.org/10.1016/j.nucmedbio.2020.11.005.
Selection of the First 99mTc-Labelled Somatostatin Receptor Subtype 2 Antagonist for Clinical Translation—Preclinical Assessment of Two Optimized Candidates.
Fani, M.; Weingaertner, V.; Kolenc Peitl, P.; Mansi, R.; Gaonkar, R.H.; Garnuszek, P.; Mikolajczak, R.; Novak, D.; Simoncic, U.; Hubalewska-Dydejczyk, A.; Rangger, C.; Kaeopookum, P; Decristoforo, C.
Pharmaceuticals 2021, 14, 19.
https://dx.doi.org/doi:10.3390/ph14010019.
SPECT Imaging of SST2-Expressing Tumors with 99mTc-Based Somatostatin Receptor Antagonists: The Role of Tetraamine, HYNIC, and Spacers.
Gaonkar, R.H.; Wiesmann, F.; Del Pozzo, L.; McDougall, L.; Zanger, S.; Mikołajczak, R.; Mansi, R.; Fani, M.
Pharmaceuticals 2021, 14, 300.
https://doi.org/10.3390/ph14040300
PSMA targeted conjugates based on dextran. Appl.
M. Janczewska, M. Szkop, G. Pikusa, K. Kopyra, A. Świątkowska, K. Brygoła, U. Karczmarczyk, J. Walczak, M.T. Żuk, J. Duszak, T. Ciach.
Appl. Radiat. Isot. Vol. 167 (2021)
http://doi.org/10.1016/j.apradiso.2020.109439
PSMA-D4 Radioligand for Targeted Therapy of Prostate Cancer: Synthesis, Characteristics and Preliminary Assessment of Biological Properties.
Piotr Garnuszek , Urszula Karczmarczyk , Michał Maurin, Arkadiusz Sikora, Jolanta Zaborniak, Justyna Pijarowska-Kruszyna, Antoni Jaroń, Monika Wyczółkowska, Wioletta Wojdowska, Dariusz Pawlak, Piotr F. J. Lipiński and Renata Mikołajczak
Int. J. Mol. Sci. 2021, 22, 2731.
https://doi.org/10.3390/ijms22052731
Synthesis of HBED-CC-tris(tert-butyl ester) with using solid phase and microwave reactor.
K. Jerzyk, D. Kłudkiewicz, J. Pijarowska-Kruszyna, A. Jaroń, M. Maurin, A. Sikora, Ł. Kordowski, P. Garnuszek
Tetrahedron 84 (2021) 132018
https://doi.org/10.1016/j.tet.2021.132018
Virtual screening for small molecular non-covalent binders of the SARS-CoV-2 main protease.
Piotr F.J. Lipiński, Jolanta Zaborniak, Piotr Garnuszek, Przemysław Szurmak
Arch Med Sci 2021; 17 (3): 838–842.
https://doi.org/10.5114/aoms/133122
Design and evaluation of 223Ra-labeled and anti-PSMA targeted NaA nanozeolites for prostate cancer therapy-Part II. Toxicity, pharmacokinetics and biodistribution.
Anna Lankoff, Malwina Czerwińska, Rafał Walczak, Urszula Karczmarczyk, Kamil Tomczyk, Kamil Brzóska, Giulio Fracasso, Piotr Garnuszek, Renata Mikołajczak, Marcin Kruszewski
Int. J. Mol. Sci. 2021, 22, 5702.
https://doi.org/10.3390/ijms22115702
Optimization of microwave assisted solid-phase synthesis of octreotate peptide and coupling with protected bifunctional chelator Dota(tBu)3.
A. Sikora, M. Maurin, A. Jaroń, J. Pijarowska-Kruszyna, Ł. Kordowski, P. Garnuszek
Acta Pol. Pharm.[40] Vol. 77 No 4 (2020) 589-600
https://doi.org/10.32383/appdr/124745
Determination of tioacetic acid in meso-2,3 dimercaptosuccinic acid.
Robert Lipka, Magdalena Piekart, Małgorzata Romańczuk, Arkadiusz Nowak, Beata Kuczyńska, Łukasz Sochaczewski
Acta Pol. Pharm. Vol. 77 No. 5 pp. 709-718, 2020.
IAEA activities on 67Cu, 186Re, 47Sc Theranostic Radionuclides and Radiopharmaceuticals.
A.J. Jalilian, M.A. Gizawy, C. Alliot, S. Takacs, S. Chakraborty, M. Rovais, G. Pupillo, K. Nagatsu, J.H. Park, M.U. Khandaker, R. Mikołajczak et al.
Current Radiopharmaceuticals, 2020, 13,1-0
https://doi.org/ 10.2174/1874471013999200928162322
Methods of Investigation Transformation Kinetics of Yttrium Carbonate Hydroxide in Citric Acid Solution into Yttrium Citrate Dihydrate.
W. Janusz, E. Skwarek, D. Sternik, S. Pikus, D. Pawlak, J.L. Parus, R. Mikołajczak
MethodsX Vol. 7 No 101153 (2020) 1-7
Effect of Peptide Receptor Radionuclide Therapy (PRRT) with tandem isotopes – [90Y]Y/[177Lu]Lu-DOTATATE in patients with disseminated neuroendocrine tumours depending on qualification [18F]FDG PET/CT in Polish multicenter experience – do we need [18F]FDG.
A. Zemczak, M. Kołodziej, P. Gut, L. Królicki, B. Kos-Kudła, G. Kamiński, M. Ruchała, D. Pawlak
Endokrynologia Polska[40] (2020)
Endohedral isomerism in model achiral and chiral La@C58N2 systems.
Sławomir Ostrowski, Piotr Garnuszek, Jan Cz. Dobrowolski
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 231 (2020) 117791
https://doi.org/10.1016/j.saa.2019.117791
Activity of 177Lu-DOTA-Rituximab Preparations in Lymphoma Tumor-Bearing Mice.
W. Wojdowska, U. Karczmarczyk, L. Balog, A. Sawicka, Z. Pöstény, V. Kovács-Haász, A. Polyák, E. Laszuk, R. Mikołajczak, P. Garnuszek
Cancer. Biotherapy Radiopharm.[70] Vol. 35 No 8 (2020) 558-562
https://doi.org/10.1089/cbr.2019.3405
Tumor uptake in glioblastoma multiforme after IV injection of [177Lu]Lu-PSMA-617.
Jolanta Kunikowska, Ingeborga Charzyńska, Radosław Kuliński, Dariusz Pawlak, Michał Maurin, Leszek Królicki
European Journal of Nuclear Medicine and Molecular Imaging
https://doi.org/10.1007/s00259-020-04715-z.
225Ac- and 213Bi-Substance P Analogues for Glioma Therapy.
L. Królicki, J. Kunikowska, F. Bruchertseifer, H. Koziara, B. Królicki, M. Jakuciński, D. Pawlak, R. Rola, A. Morgenstern, E. Rosiak, A.Merlo
Semin Nucl Med Vol. 50 No 2 (2020) 141-151
https://doi.org/10.1053/j.semnuclmed.2019.11.004.
Tandem Peptide Receptor Radionuclide Therapy using 90Y/177Lu-DOTATATE for neuroendocrine tumors efficacy and side-effects – Polish multicenter experience.
J. Kunikowska, D. Pawlak, R. Mikołajczak, L. Królicki
Eur. J. Nucl. Med. Mol. Imaging [140] Vol. 47 No 4 (2020) 922-933
Comparison of PET/CT imaging with [18F]FDOPA and cholecystokinin-2 receptor targeting [68Ga]Ga-DOTA-MGS5 in a patient with advanced medullary thyroid carcinoma.
C. Uprimny, E. VonGuggenberg, A. Svirydenka, R. Mikołajczak, A. Hubalewska-Dydejczyk, I. Virgolini
Eur. J. Nucl. Med. Mol. Imaging [140] (2020)
Synthesis of yttrium citrate from yttrium carbonate hydroxide and citric acid.
W. Janusz, E. Skwarek, D. Sternik, S. Pikus, D. Pawlak, J.L. Parus, R. Mikołajczak
Mater. Chem. Phys. [70] Vol. 250 (2020) 123113
Comparison of separation methods for 47Ca/47Sc radionuclide generator.
D. Pawlak, W. Wojdowska, J.L. Parus, I. Cieszykowska, M. Żółtowska, P. Garnuszek, R. Mikołajczak
Appl. Radiat. Isot. Vol. 151 (2019) 140-144
https://doi.org/10.1016/j.apradiso.2019.05.020.
Translation of preclinical development into a clinical theranostic agent.
P. KolencPeitl, Ch. Rangger, P. Garnuszek, R. Mikołajczak, A. Hubalewska-Dydejczyk, Th. Maina, P. Erba, C. Decristoforo
J Labelled Comp Radiopharm. Vol. 62 (2019) 1-11
https://doi.org/10.1002/jlcr.3712.
Radiometals for imaging and theranostics, current production, and future perspectives.
R. Mikołajczak, N.P. Van der Mullen, S.E. Lapi
J Labelled Comp Radiopharm. Vol. 62 (2019) 615
https://doi.org/10.1002/jlcr.3770.
Superior diagnostic performance of the GLP-1 receptor agonist [Lys40(AhxHYNIC-99mTc/EDDA)NH2]-exendin-4 over conventional imaging modalities for localization of insulinoma.
Senica, A. Tomazic, A. Skvarca, P. Kolenc-Peitl, R. Mikołajczak, A. Hubalewska-Dydejczyk, L. Lezaic
MOL IMAGING BIOL Vol. 019 No 01372 (2019) 1-8
https://doi.org/10.1007/s11307-019-01372-z
Improved procedures of Sc(OH)3 precipitation and UTEVA extraction for 44Sc separation.
W. Wojdowska, D. Pawlak, I. Cieszykowska, M. Żółtowska, T. Janiak, T. Barcikowski, A. Stolarz, J. Choiński, J.L. Parus, P. Garnuszek, R. Mikołajczak
Nucl Med Rev Vol. 22 No 2 (2019) 1-4.
https://doi.org/10.5603/NMR.a2019.0013
In vitro and in vivo evaluation of the new 99mTc labelled PSMA tracers in prostate cancer diagnosis.
M. Maurin, A. Sikora, M. Wyczółkowska, U. Karczmarczyk, P. Garnuszek
Eur. J. Nucl. Med. Mol. Imaging Vol. 46 (Sup 1) (2019)
Radiometals for imaging and theranostics, current production, and future perspectives.
R. Mikołajczak, N.P. VanderMullen, S.E. Lapi
J Labelled Comp Radiopharm Vol. 62 (2019) 615
15 years of observation – selected meteorite falls registered in the PFN in 2004–2019
Z. Tymiński, … , … et al.
Acta Soci Metheor Polonorum Vol. 10 (2019) 160-167
Improved procedures of Sc(OH)3 precipitation and UTEVA extraction for 44Sc separation
W. Wojdowska, … , D. Pawlak, I. Cieszykowska, M. Żółtowska, T. Janiak, T. Barcikowski, J.L. Parus, P. Garnuszek, R. Mikołajczak, … et al.
Nucl Med Rev Vol. 22 (2019) 1-4
Comparison of separation methods for 47Ca/47Sc radionuclide generator
D. Pawlak, W. Wojdowska, J.L. Parus, I. Cieszykowska, M. Żółtowska, P. Garnuszek, R. Mikołajczak
Appl. Radiat. Isot. Vol. 151 (2019) 140-144
Superior diagnostic performance of the GLP-1 receptor agonist [Lys40(AhxHYNIC-99mTc/EDDA)NH2]-exendin-4 over conventional imaging modalities for localization of insulinoma
KatraSenica, AlesTomazic, AlesSkvarca, PetraKolencPeitl, R. Mikołajczak, AlicjaHubalewska-Dydejczyk, LukaLezaic
MOL IMAGING BIOL Vol. 019 (2019) 1-8
Wide acceptance measurement of K−/K+ ratio from Ni+Ni collisions at 1.91A GeV
K. Piasecki, … , V. Charviakova, M. Kirejczyk, Z. Tymiński, … et al.
Phys. Rev. C Vol. 99 (2019) 014904
Clinical translation of theranostic radiopharmaceuticals: Current regulatory status and recent examples.
P. KolencPeitl, … , P. Garnuszek, R. Mikołajczak, … et al.
J Labelled Comp Radiopharm Vol. SIA (2019) 1-11
Report on meteorite field search within PFN in 2016/2017 season
Z. Tymiński, … , … et al.
Acta Soci Metheor Polonorum Vol. 9 (2018) 158-163
Mobile and Multipoint Temperature Measurement Systems Based on Pt100 Sensors for Future Study of Energy Emitted from the Uranium Experimental Assembly
I. Dusza, M. Bielewicz, P. Antkowiak, P. Rybak, M. Peryt, K. Roslon
Acta Phys. Pol. B Proc. Suppl. Vol. 11 (2018) 731-737
A novel CCK2/gastrin receptor-localizing radiolabeled peptide probe for personalized diagnosis and therapy of patients with progressive or metastatic medullary thyroid carcinoma -GRAN-T-MTC – a multicenter phase I study
P.A. Erba, … , R. Mikołajczak, P. Garnuszek, D. Pawlak, … et al.
Pol Arch Intern Med Vol. 128 (2018) 791-795
Pomiary izotopów gamma promieniotwórczych w trynitytach.
Z. Tymiński, … , A. Burakowska, K. Tymińska, E. Kołakowska, P. Saganowski, T. Ziemek, T. Dziel, … et al.
Acta Socie. Metheori. Polonorum Vol. 9 (2018) 150-157
Historia oraz stan obecny Polish Fireball Network
M. Wiśniewski, … , Z. Tymiński, … et al.
Acta Socie. Metheori. Polonorum Vol. 9 (2018) 177-186
Influence of DOTA Chelators on Radiochemical Purity and Biodistribution of 177Lu- and 90Y-Rituximab in Xenografted Mice
U. Karczmarczyk, W. Wojdowska, R. Mikołajczak, M. Maurin, E. Laszuk, P. Garnuszek
IRAN J PHARM RES Vol. 17 (2018) 1201-1208
Results of the CCRI(II)-S12.H-3 supplementary comparison: Comparison of methods for the calculation of the activity and standard uncertainty of a tritiated-water source measured using the LSC-TDCR method
P. Cassette, … , T. Ziemek, … et al.
Appl. Radiat. Isot. Vol. 134 (2018) 257-262
Results of an international comparison of activity measurements of 68Ge
J.T. Cessna, … , T. Dziel, A. Listkowska, Z. Tymiński, … et al.
Appl. Radiat. Isot. Vol. 134 (2018) 385-390
Comparison of I-131 activity measurements at the NCBJ RC POLATOM and the ENEA-INMRI linked to the BIPM SIR system
T. Ziemek, M. Capogni, G. Ratel, R. Broda, T. Dziel, A. Fazio, A. Listkowska
Appl. Radiat. Isot. Vol. 134 (2018) 380-384
Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma
L. Królicki, … , D. Pawlak, … et al.
Eur J Nucl Med Mol Imag Vol. 018 (2018) 1-9
Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with 213Bi-substance P analogue
L. Królicki, … , D. Pawlak, … et al.
Eur J Nucl Med Mol Imag Vol. 48 (2018) 1636–1644
Cosmic Ray Extremely Distributed Observatory: a global network of detectors to probe contemporary physics mysteries
K. AlmeidaCheminant, … , M. Kasztelan, M. Pawlik, … et al.
Acta Phys. Pol. B Proc. Suppl. Vol. 11 (2018) 489
The effects of iospropyl methylphosphonofluoridate (IMPF) poisoning on tumour growth and angiogenesis in BALB/c mice.
R. Zdanowski, M. Leśniak, U. Karczmarczyk, M. Saracyn, M. Bilski, A. Kiepura, S. Lewicki
ANN TRANSPL Vol. 23 (2018) 105-111
Relation between modulation frequency of electric power oscillation during pulse magnetron sputtering deposition of MoNx thin films
B. Wicher, … , K. Nowakowska-Langier, Ł. Kurpaska, … et al.
Appl. Surf. Sci. Vol. 456 (2018) 789
Impurities in Tc-99m radiopharmaceutical solution obtained from Mo-100 in cyclotron
Z. Tymiński, P. Saganowski, E. Kołakowska, A. Listkowska, T. Ziemek, D. Cacko, T. Dziel
Appl. Radiat. Isot. Vol. 134 (2018) 85-88
Preparation method and quality control of multigamma volume sources with different matrices
A. Listkowska, … , E. Lech, P. Saganowski, Z. Tymiński, T. Dziel, D. Cacko, T. Ziemek, E. Kołakowska, R. Broda, … et al.
Appl. Radiat. Isot. Vol. 134 (2018) 126-130
New synthesis route of active substance d,l-HMPAO for preparation Technetium(99mTc) exametazine
J. Pijarowska-Kruszyna, … , U. Karczmarczyk, A. Jaroń, E. Laszuk, M. Radzik, P. Garnuszek, R. Mikołajczak, … et al.
Nucl Med Rev Vol. 20 (2017) 88-94
Nauka – edukacja – przemysł: synergiczna współpraca dlainnowacyjności
M. Bartosik, … , A. Strupczewski, … et al.
Przegląd Elektrotechniczny Vol. 93 (2017) 339–345
Long term results and tolerability of tandem peptide receptor radionuclide therapy with 90Y/177Lu-DOTATATE in neuroendocrine tumors with respect to the primary location: a 10-year study.
J. Kunikowska, D. Pawlak, M.I. Bąk, B. Kos-Kudła, R. Mikołajczak, L. Królicki
ANN NUCL MED Vol. 31 (2017) 347
Bilateral comparison of C-14 activity measurements at the NCBJ RC POLATOM and the ENEA-INMRI
T. Ziemek, … , R. Broda, T. Dziel, A. Jęczmieniowski, E. Lech, A. Listkowska, Z. Tymiński, … et al.
J. Radioanal. Nucl. Chem. Vol. 314 (2017) 721-725
PF120916 Piecki fireball and Reszel meteorite fall
A. Olech, … , Z. Tymiński, … et al.
Contributions of the Astronomical Observatory Skalnate Pleso Vol. 47 (2017) 19-28
177Lu Labeled Cyclic Minigastrin Analogues with Therapeutic Activity in CCK2R Expressing Tumors: Preclinical Evaluation of a Kit Formulation
Chr. Rangger, … , D. Pawlak, R. Mikołajczak, … et al.
MOL PHARM Vol. 14 (2017) 3045-3058
Current status of Polish Fireball Network.
M. Wiśniewski, … , Z. Tymiński, … et al.
Planetary and Space Sci. Vol. 143 (2017) 12-20
Enhanced activity of the Southern Taurids in 2005 and 2015
A. Olech, … , Z. Tymiński, … et al.
Mon. Not. R. Astron. Soc. Vol. 469 (2017) 2077-2088
Manufacturing and characterization of molybdenum pellets used as targets for 99mTc production in cyclotron.
I. Cieszykowska, … , T. Janiak, T. Barcikowski, M. Mielcarski, R. Mikołajczak, M. Barlak, Ł. Kurpaska, … et al.
Appl. Radiat. Isot. Vol. 124 (2017) 124-131
Realisation of radionuclides activity unit using the liquid scintillation counting (LSC) – Odtwarzanie jednostki aktywności radionuklidów za pomocą techniki ciekłych scyntylatorów (LSC)
R. Broda, T. Dziel, A. Listkowska, T. Ziemek
Informatyka, Automatyka, Pomiary w gospodarce i ochronie środowiska (2016) 28-31
Pomiary 60Co w obiektach z żelazną matrycą.
Z. Tymiński, … , T. Dziel, P. Saganowski, E. Kołakowska, A. Listkowska, K. Tymińska, … et al.
Acta Soci Metheor Polonorum Vol. 7 (2016) 144-150
Strange meson production in Al+Al collisions at 1.9 A GeV
P. Gasik, … , M. Kirejczyk, … et al.
Eur. Phys. J. A Vol. 52 (2016) 177
Magazynowanie energii elektrycznej i gospodarka wodorowa
M. Bartosik, … , A. Strupczewski, … et al.
Przegląd Elektrotechniczny Vol. 92 (2016) 332-340
Przesył energii elektrycznej – potrzeby,progi i bariery
M. Bartosik, … , A. Strupczewski, … et al.
Przegląd Elektrotechniczny Vol. 92 (2016) 295-300
Wytwarzanie energii elektrycznej – diagnoza i terapia
M. Bartosik, … , A. Strupczewski, … et al.
Przegląd Elektrotechniczny Vol. 92 (2016) 277–286
Polityka i porządek prawny w polskiej energetycena tle polityki Unii Europejs
M. Bartosik, … , A. Strupczewski, … et al.
Przegląd Elektrotechniczny Vol. 92 (2016) 287–295
Magazynowanie energii elektrycznej i gospodarka wodorowa
M. Bartosik, … , A. Strupczewski, … et al.
Przegląd Elektrotechniczny Vol. 92 (2016) 332-340
Bezpieczeństwo elektroenergetyczne dla pokoleń
M. Bartosik, … , A. Strupczewski, … et al.
Przegląd Elektrotechniczny Vol. 92 (2016)
A new 4∏(LS)-γ coincidence counter at NCBJ RC POLATOM with TDCR detector in the beta channel
T. Ziemek, A. Jęczmieniowski, D. Cacko, R. Broda, E. Lech
Appl. Radiat. Isot. (2016) 290-295
A new large-volume metal reference standard for radioactive waste management
F. Tzika, … , A. Listkowska, Z. Tymiński, … et al.
Radiat. Prot. Dosim. Vol. 168 (2016) 293
2015 Southern Taurid fireballs and asteroids 2005 UR and 2005 TF50
A. Olech, … , Z. Tymiński, … et al.
Mon. Not. R. Astron. Soc. Vol. 461 (2016) 674-683
60Co in Cast Steel Matrix: a European Interlaboratory Comparison for the Characterisation of New Activity Standards for Calibration of Gamma-ray Spectrometers in Metallurgy
F. Tzika, … , Z. Tymiński, … et al.
Appl. Radiat. Isot. Vol. 114 (2016) 167
Centrality dependence of subthreshold Phi meson production in Ni+Ni collisions at 1.9A GeV
K. Piasecki, … , Z. Tymiński, M. Kirejczyk, … et al.
Phys. Rev. C Vol. 94 (2016) 014901
90Y microspheres prepared by sol-gel method, promising medical material for radioembolization of liver malignancies
W. Łada, E. Iller, D. Wawszczak, M. Konior, T. Dziel
Mat. Sci. Eng. C Vol. 67 (2016) 629–635
Standardisation and half-life measurements of 111In
T. Dziel, A. Listkowska, Z. Tymiński
Appl. Radiat. Isot. Vol. 109 (2016) 345-348
Radionuclidic purity tests in 18F radiopharmaceuticals production process
T. Dziel, Z. Tymiński, K. Sobczyk, A. Walęcka-Mazur, P. Kozanecki
Appl. Radiat. Isot. Vol. 109 (2016) 242-246
Radiopharmaceuticals for somatostatin receptor imaging
R. Mikołajczak, H.R. Maecke
Nucl Med Rev Vol. 19 (2016) 126-132
Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with 111In-CP04 in medullary thyroid carcinoma patients.
T. Maina, … , P. Garnuszek, R. Mikołajczak, … et al.
EUR J PHARM SCI Vol. 91 (2016) 236-42
Application of Analig resin for 99mTc separation from 100Mo target irradiated in cyclotron
D. Pawlak, W. Wojdowska, J.L. Parus, R. Mikołajczak
Appl. Radiat. Isot. Vol. 113 (2016) 75-78
A one-step automated synthesis of the dopamine transporter ligand [18F]FECNT from the chlorinated precursor
J. Pijarowska-Kruszyna, A. Jaroń, A. Kachniarz, B. Małkowski, P. Garnuszek, R. Mikołajczak
J Labelled Comp Radiopharm Vol. 59 (2016) 82-86
99mTc Labeled Glucagon-Like Peptide-1- Analogue (99mTc-GLP1) Scintigraphy in the Management of Patients with Occult Insulinoma
A. Sowa-Staszczak, … , R. Mikołajczak, B. Janota, … et al.
PLOS One Vol. 11 (2016) e0160714
68Ga-DOTATATE PET in juvenile angiofibroma
Z. Gronkiewicz, W. Kukwa, L. Krolicki, A. Cyran-Clebicka, D. Pawlak, C. Stankiewicz
Future Oncol Vol. 12 (2016) 1483-1491
Editorial. Special issue: Somatostatin Receptor Scintigprahy in NEN
R. Mikołajczak, GrzegorzKamiński
Nucl Med Rev Vol. 19 (2016) 1
Oxidation of methionine — is it limiting the diagnostic properties of 99mTc-labeled Exendin-4, a Glucagon-Like Peptide-1 receptor agonist?
B. Janota, U. Karczmarczyk, E. Laszuk, P. Garnuszek, R. Mikołajczak
Nucl Med Rev Vol. 19 (2016) 104-110
Influence of PET/CT 68Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with 99mTc-EDDA/HYNIC-TOC SPECT
D. Mądrzak, R. Mikołajczak, G. Kamiński
Nucl Med Rev Vol. 19 (2016) 88-92
From preclinical development to clinical application: Kit formulation for radiolabelling the minigastrin analogue CP04 with In-111 for a first-in-human clinical trial.
D. Pawlak, … , P. Garnuszek, M. Maurin, R. Mikołajczak, … et al.
EUR J PHARM SCI Vol. 85 (2016) 1-9
Medullary thyroid carcinoma – PET/CT imaging with 68Ga-labelled gastrin and somatostatin analogues
J. Kunikowska, … , D. Pawlak, R. Mikołajczak, … et al.
Endokrynologia Polska Vol. 67 (2016) 68-71
Prospekcja powierzchniowa składu pierwiastkowego gleby w rezerwacie Meteoryt Morasko (Surface prospection of soil samples elemental composition originate from Meteoryt Morasko reserve)
E. Miśta-Jakubowska, Z. Tymiński, P. Kalbarczyk
Acta Soci Metheor Polonorum Vol. 6 (2015) 96-102
Molybdenum targets produced by mechanical reshaping
A. Stolarz, J.A. Kowalska, P. Jasiński, T. Janiak, J. Samorajczyk
J. Radioanal. Nucl. Chem. Vol. 305 (2015) 947-952
Interlaboratory comparison on 137Cs activity concentration in fume dust
F. Tzika, … , Z. Tymiński, … et al.
Radiat. Phys. Chem. Vol. 116 (2015) 106-110
PF131010 Ciechanow fireball – the body possible related to Near Earth Asteroids 2010 TB54 and 2010 SX11
A. Olech, … , Z. Tymiński, … et al.
Mon. Not. R. Astron. Soc. Vol. 454 (2015) 2965–2971
Determination of the 151Sm half-life.
M-M. Bé, … , T. Dziel, … et al.
Radiochim. Acta Vol. 103 (2015) 619-626
Characterisation of a radionuclide specific laboratory detector system for the metallurgical industry by Monte Carlo simulations
J. Solc, … , T. Dziel, … et al.
Radiat. Phys. Chem. Vol. 116 (2015) 189-193
Update of the BIPM comparison BIPM.RI(II)-K1.Sr-85 of activity measurements of the radionuclide 85Sr to include the 2009 result of the POLATOM (Poland)
C. Michotte, G. Ratel, S. Courte, T. Dziel, A. Listkowska
Metrologia Vol. 52 (2015) 06022
Results of the EURAMET.RI(II)-S7.Sm-151 supplementary comparison (EURAMET Project 1292)
M.-M. Be, … , T. Dziel, … et al.
Metrologia Vol. 52 (2015) 06016
The radiometal makes a differences. Synthesis and preliminary characterisation of DOTA-minigastrin analogue complexes with Ga, Lu and Y.
M. Maurin, P. Garnuszek, P. Baran, D. Pawlak, R. Mikołajczak
Nucl Med Rev Vol. 18 (2015) 51-55
Studies on the separation of 99mTc from large excess of molybdenum
W. Wojdowska, D. Pawlak, J.L. Parus, R. Mikołajczak
Nucl Med Rev Vol. 18 (2015) 65-69
177Lu-Labeled Zirconia Particles for Radiation Synovectomy
AndrasPolyak, … , R. Mikołajczak, … et al.
Cancer. Biotherapy Radiophar. Vol. 30 (2015) 433-438
How often do we see incidental 68Ga-DOTATATE thyroid uptake in PET/CT in patients with neuroendocrine tumours?
J. Kunikowska, R. Matyskiel, A. Zemczak, J. Strzelczyk, D. Pawlak, L. Królicki, B. Kos-Kudła
Endokrynologia Polska Vol. 66 (2015) 231
Uncertainty determination for activity measurements by means of the TDCR method and the CIEMAT/NIST efficiency tracing technique
K. Kossert, R. Broda, P. Cassette, G. Ratel, B. Zimmerman
Metrologia Vol. 52 (2015) S172-S190
Standardization of 153Sm solution by absolute methods
T. Dziel, R. Broda, T. Ziemek, A. Muklanowicz, A. Listkowska
Appl. Radiat. Isot. Vol. 87 (2014) 19-23
Proficiency tests of 90Y and 89Sr activity measurements in Polish hospitals
T. Dziel, A. Listkowska, Z. Tymiński
Appl. Radiat. Isot. Vol. 87 (2014) 24-26
Evaluation of dead-time corrections for post-radionuclide therapy 177Lu quantitative imaging with low-energy high-resolution collimators
A. Celler, H. Piwowarska-Bilska, S. Shcherbinin, C. Uribe, R. Mikołajczak, B. Birkenfeld
Nuclear Medicine Communications Vol. 31 (2014) 73-78
Synthesis of novel halo and tosyloxy nortropane derivatives as efficient precursors for the one-step synthesis of the dopamine transporter PET ligand [18F]FECNT
J. Pijarowska-Kruszyna, … , A. Jaroń, R. Mikołajczak, … et al.
J. Labelled Comp. & Radiophar. Vol. 57 (2014) 148-157
A frequency and semiquantitative analysis of pathological 68Ga DOTATATE PET/CT uptake by primary site-dependent neuroendocrine tumor metastasis
J. Kunikowska, D. Pawlak, A. Kolasa, R. Mikołajczak, L. Królicki
Clinical Nuc. Med. Vol. 39 (2014) 855-861
Synthesis and structural investigations of gel metal oxide composites WO3-ZrO2, WO3-TiO2, WO3-ZrO2-SiO2, and their evaluation as materials for the preparation of 188W/188Re generator
E. Iller, D. Wawszczak, M. Konior, H. Polkowska-Motrenko, J.J. Milczarek, L. Górski
Appl. Radiat. Isot. Vol. 75 (2013) 115-127
Powstawanie kraterów impaktowych i ich rodzaje.
T. Brachaniec, Z. Tymiński, A. Broszkiewicz
Acta Soci Metheor Polonorum Vol. 5 (2013) 30-46
Pomiary radionuklidów kosmogenicznych w meteorycie z Oslo i interpretacja wyników.
Z. Tymiński, E. Miśta-Jakubowska, P. KALBARCZYK
Acta Socie. Metheori. Polonorum Vol. 4 (2013) 115
Nephrotoxicity after PRRT – still a serious clinical problem? Renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATATE and 90Y/177Lu-DOTATATE.
J. Kunikowska, L. Królicki, A. Sowa-Staszczak, D. Pawlak, A. Hubalewska-Dydejczyk, R. Mikołajczak
Endokrynologia Polska Vol. 64 (2013) 13-20
A study of selected properties of rhenium sulphide dispersion
D. Pawlak, J.L. Parus, E. Skwarek, W. Janusz
Physicochem. Probl. Miner. Process. Vol. 50 (2013) 387-397
PF191012 Myszyniec – highest Orionid meteor ever recorded
A. Olech, … , Z. Tymiński, … et al.
Astron. Astrophys. Vol. 557 (2013) A89
Radioactive waste management: Review on clearance levels and acceptance criteria legislation, requirements and standards
F.J. Maringer, … , Z. Tymiński, … et al.
Appl. Radiat. Isot. Vol. 81 (2013) 255
Determination of 90Sr traces in medical 90Y after separation on DGA column
D. Pawlak, J.L. Parus, T. Dziel, A. Muklanowicz, R. Mikołajczak
Talanta Vol. 1-4 (2013) 114
Glucagon-like peptide-1 receptor imaging with [Lys 40(Ahx-HYNIC-99mTc/EDDA)NH2 ]-exendin-4 for the detection of insulinoma
A. Sowa-Staszczak, … , R. Mikołajczak, B. Janota, … et al.
Eur. J. Nucl. Med. Mol. Imaging Vol. 40 (2013) 524-531
Semiquantitative analysis and characterization of physiological biodistribution of (68)Ga-DOTA-TATE PET/CT.
J. Kunikowska, L. Królicki, D. Pawlak, I. Zerizer, R. Mikołajczak
Clinical Nuc. Med. Vol. 37 (2013) 1052-57
Radiofarmaceutyki: aspekty kontroli jakości zawartości substancji czynnej na przykładzie kwasu metylenodifosfonowego (MDP)
J. Staniszewska, E. Bulska
Analityka : nauka i praktyka Vol. 4 (2013) 4-10
Different technical possibilities of post-therapeutic tandem 90Y/177Lu-DOTATATE imaging
J. Kunikowska, … , D. Pawlak, … et al.
Nucl Med Rev Vol. 16 (2013) 70-73
Glucagon-like Peptide-1 Receptor Imaging with [Lys40(Ahx-HYNIC-99mTc/EDDA)NH2]-Exendin-4 for the Diagnosis of Recurrence or Dissemination of Medullary Thyroid Cancer: A Preliminary Report
D. Pach, … , R. Mikołajczak, B. Janota, … et al.
Int. J. of Endocrinology Vol. 2013 (2013) 384508
Recombinant fragment of an antibody tailored for direct radioiodination
J. Sedláček, … , A. Sawicka, R. Mikołajczak, … et al.
J. Labelled Comp. & Radiophar. Vol. 1 (2012) 55
Results of an international comparison for the activity measurement of 177Lu.
B.E. Zimmerman, … , T. Dziel, … et al.
Appl. Radiat. Isot. Vol. 70 (2012) 1825-1830
Standardization of the 85Sr solution by three methods
R. Broda, T. Dziel, A. Muklanowicz
Appl. Radiat. Isot. Vol. 70 (2012) 2222-2226
Imaging of inflamed carotid artery atherosclerotic plaques with the use of 99mTc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients
M. Opalinska, … , R. Mikołajczak, P. Garnuszek, M. Maurin, U. Karczmarczyk, … et al.
Eur. J. Nucl. Med. Mol. Imaging Vol. 39 (2012) 673-682
Pharmaceutical development on DOTA-anti-CD20 monoclonal antibody for Lu-177 labelling
W. Wojdowska, U. Karczmarczyk, E. Byszewska, P. Garnuszek, R. Mikołajczak
Eur. J. Nucl. Med. Mol. Imaging Vol. SUP2 (2012) S533-S533
Beta-emitting radionuclides for peptide receptor radionuclide therapy
J. Parus, R. Mikołajczak
Curr. Top. Med. Chem. Vol. 12 (2012)
Clinical indications to the use of 99mTc-EDDA/HYNIC-TOC to detect somatostatin receptor-positive neuroendocrine tumors
M.G. Parisella, … , R. Mikołajczak, … et al.
Q J Nucl Med Mol Imaging Vol. 56 (2012) 90-98
44Sc-DOTA-BN[2-14]NH2 in comparison to 68Ga-DOTA-BN[2-14]NH2 in pre-clinical investigation. Is 44Sc a potential radionuclide for PET?
E. Koumarianou, … , D. Pawlak, R. Mikołajczak, … et al.
Appl. Radiat. Isot. Vol. 70 (2012) 2669-2676
Recombinant fragment of an antibody tailored for direct radioiodination
J. Sedláček, … , R. Mikołajczak, … et al.
J Labelled Comp Radiopharm Vol. 55 (2012) 52 – 56
Nanodosimetry of Auger Electrons – experiment and modelling
S. Pszona, A. Bancer, B. Grosswendt, W. Czarnacki, I. Cieszykowska
Radiat. Meas. Vol. 47 (2012) 1092-1096
Comparison of chromatographic methods for quality control of DMSA complexes with 99mTc and 188Re at (III) and (V) oxidation states
P. Garnuszek, D. Pawlak, M. Maurin, D. Jankovic, U. Karczmarczyk, R. Mikołajczak
Nucl Med Rev Vol. 15 (2012) 95-100
Search of radiation hormesis in plants: irradiation of the cress (Lepidium sativum L.)
K. Fornalski, Ł. Adamowski, T.W. Turowski, J. Wojnarowicz
Nukleonika Vol. 57 (2012) 421
Radiopharmaceuticals in Cardiology
R. Mikołajczak, P. Garnuszek
Nucl Med Rev Vol. 15 (2012) 39-45
Repeated cycles of peptide receptor radionuclide therapy (PRRT) – Results and side-effects of the radioisotope (90)Y-DOTA TATE, (177)Lu-DOTA TATE or (90)Y/(177)Lu-DOTA TATE therapy in patients with disseminated NET.
D. Pach, … , R. Mikołajczak, D. Pawlak, … et al.
Radiother. Oncol. Vol. 102 (2012) 45-50
Ga-68 labelling of of DOTATATE for clinical application in PET/CT of neuroendocrine tumors
D. Pawlak, J. Kunikowska, L. Królicki, W. Wojdowska, L. Grabowska, R. Mikołajczak
J Labelled Comp Radiopharm Vol. 54 (2011) S343-S343
Synthesis and quality control of Ga-68-citrate for PET/CT, preliminary results
D. Pawlak, W. Wojdowska, J. Kunikowska, J. Marchel, L. Królicki, R. Mikołajczak
J Labelled Comp Radiopharm Vol. 54 (2011) S342-S342
Production of 18F by Proton Irradiation of C6H6NF and C6H5NF2
E. Betak, R. Mikołajczak, J. Staniszewska, S. Mikołajewski, E. Rurarz, J. Wojtkowska
Nukleonika Vol. 56 (2011) 269-276
Thermal diffusion of 57Co into rhodium matrix as a second step in preparing Mössbauer sources
I. Cieszykowska, M. Żółtowska, P. Zachariasz, A. Piasecki, T. Janiak, M. Mielcarski
Appl. Radiat. Isot. Vol. 69 (2011) 1193-1197
Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs)
A. Sowa-Staszczak, … , R. Mikołajczak, D. Pawlak, … et al.
Eur. J. Nucl. Med. Mol. Imaging Vol. 38 (2011) 1669-1674
Clinical results of radionuclide therapy of neuroendocrine tumours with (90)Y-DOTATATE and tandem (90)Y/ (177)Lu-DOTATATE: which is a better therapy option?
J. Kunikowska, L. Królicki, A. Hubalewska-Dydejczyk, R. Mikołajczak, A. Sowa-Staszczak, D. Pawlak
Eur. J. Nucl. Med. Mol. Imaging Vol. 38 (2011) 1788-1797
Can treatment using radiolabelled somatostatin analogue increase the survival rate in patients with non-functioning neuroendocrine pancreatic tumours?
A. Sowa-Staszczak, … , R. Mikołajczak, D. Pawlak, … et al.
Nucl Med Rev Vol. 14 (2011) 73-78
Comparison of receptor affinity of natSc-DOTA-TATE versus natGa-DOTA-TATE
E. Koumarianou, D. Pawlak, A. Korsak, R. Mikołajczak
Nucl Med Rev Vol. 14 (2011) 85-89
Efficacy and safety of (90)Y-DOTATATE therapy in neuroendocrine tumours
A. Sowa-Staszczak, … , R. Mikołajczak, … et al.
Endokrynologia Polska Vol. 62 (2011) 392-400
Patient-Specific Radiation Dosimetry of 99mTc-HYNIC-Tyr3-Octreotide in Neuroendocrine Tumors
J. Grimes, … , R. Mikołajczak, … et al.
J Nucl Med Vol. 52 (2011) 1474-1481
The penetration of topically applied ointment containing hyaluronic acid in rabbits tissues
B. Birkenfeld, … , R. Mikołajczak, E. Byszewska-Szpocińska, … et al.
Polish J Veterinary Sci. Vol. 14 (2011) 621-627
Electrodeposition of carrier-free 57Co on rhodium as an approach to the preparation of Mössbauer sources
I. Cieszykowska, M. Żółtowska, M. Mielcarski
Appl. Radiat. Isot. Vol. 69 (2011) 142-145
Comparison of triple-to-double coincidence ratio (TDCR) efficiency calculations and uncertainty assessments for 99Tc.
B.E. Zimmerman, … , R. Broda, … et al.
Appl. Radiat. Isot. Vol. 68 (2010) 1477-1481
Comparison of 99Tcm and 131I in Polish hospitals, 2007
R. Broda, T. Dziel, A. Muklanowicz, A. Listkowska, Ł. Pieńkowski, A. Patocka, E. Kołakowska
Appl. Radiat. Isot. Vol. 68 (2010) 1278-1281
COSTBM0607-WG2, Preparation of therapeutic doses of Lu-177 or Y-90 DOTATATE for PRRT
D. Pawlak, W. Wojdowska, R. Mikołajczak
Nucl. Med. Biol. Vol. 37 (2010) 723-723
Multispecies animal investigation on biodistribution, pharmacokinetics and toxicity of 177Lu-EDTMP, a potential bone pain palliation agent
D. Máthé, … , D. Pawlak, … et al.
Nucl. Med. Biol. Vol. 37 (2010) 215-226
Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs) a phase II study
J.B. Ćwikła, … , R. Mikołajczak, D. Pawlak, … et al.
Ann. Oncolog. Vol. 21 (2010) 787-794
Guidance on current good radiopharmacy practice (cGRRP) for the small scale preparation of radiopharmaceuticals
P. Elsinga, … , R. Mikołajczak, … et al.
Eur. J. Nucl. Med. Mol. Imaging Vol. 37 (2010) 1049-1062
Investigation of 99mTc-labelling of recombinant human interleukin-2 via hydrazinonicotinamide
U. Karczmarczyk, P. Garnuszek, M. Maurin, V. DiGialleonardo, F. Galli, A. Signore, R. Mikołajczak
Nucl. Med. Biol. Vol. 37 (2010) 795-803
Application of neutron activation analysis for identification of cosmic mater on earth
Z. Tymiński, B. Mysłek-Laurikainen
Acta Soci Metheor Polonorum Vol. 1 (2009) 97
Państwowy wzorzec jednostki miary aktywności promieniotwórczej radionuklidów.
T. Dziel, R. Broda
Metrologia Vol. 12 (2009) 19 – 27
TOWARDS THE DEVELOPMENT OF PHARMACEUTICAL KIT FOR GALLIUM-68 LABELLING OF DOTATATE
D. Pawlak, Z. Wygoda, W. Wojdowska, R. Mikołajczak
J Labelled Comp Radiopharm Vol. 52 (2009) S264-S264
Electroplating nickel on to uranium as fission – recoil barrier
I. Cieszykowska, M. Żółtowska, M. Mielcarski
Nukleonika Vol. 54 (2009) 29-32
Evaluation of radiological and clinical efficacy of 90Y- DOTATATE therapy in patients with progressive metastatic midgut neuroendocrine carcinomas
J.B. Ćwikła, … , R. Mikołajczak, D. Pawlak, … et al.
Pol. J. Radiol. Vol. 74 (2009) 7-15
Identification of inflamed atherosclerotic plaque using 123I -labeled interleukin-2 scintigraphy in high-risk peritoneal dialysis patients a pilot study
A. Hublewska-Dydejczyk, … , R. Mikołajczak, U. Karczmarczyk, … et al.
Perit. Dial. Int. Vol. 2 (2009) 568-574
Comparative study on DOTA-derivatized bombesin analog labeled with 90Y and 177Lu in vitro and in vivo evaluation
E. Koumarianou, … , R. Mikołajczak, D. Pawlak, P. Garnuszek, U. Karczmarczyk, M. Maurin, … et al.
Nucl. Med. Biol. Vol. 36 (2009) 591-603
Studies of gel metal-oxide composite samples as filling materials for W-188/Re-188 generator column
E. Iller, … , M. Konior, J.J. Milczarek, J. Żołądek-Nowak, … et al.
J. Radioanal. Nucl. Chem. Vol. 281 (2009) 83-86
Labeling of Engineered Antibody Fragments scFvTU20 with 125I
A. Sawicka, E. Byszewska, R. Mikołajczak, L. Konrad, J. Sedlacek, M. Mudra
Eur. J. Nucl. Med. Mol. Imaging Vol. 35 (Suppl (2008) S2 16-S402
Some remarks on photons statistics in the LS-counter
R. Broda
Appl. Radiat. Isot. Vol. 66 (2008) 1062-1066
Metody kontroli jakościradiofarmaceutyków i promieniotwórczych związków chemicznych stosowanych w medycynie
J. Staniszewska, E. Bulska
Analityka : nauka i praktyka (2008) 51-54
Simultaneous determination of ethylenediamine-N,N,N’,N’-tetrakismethylene phosphonate and ascorbic acid in “cold” radiopharmaceutical kit.
R. Lipka, El. Jakubowska
Acta Pol. Pharm. Vol. 65 (2008) 507
Usefulness of SPECT/CT with 99mTc-HYNIC-IgG (POLATOM,Poland) for detection and preoperative diagnosis of inflammation in skeletal system.
M. Górska-Chrząstek, … , E. Byszewska-Szpocińska, R. Mikołajczak, … et al.
Eur. J. Nucl. Med. Mol. Imaging Vol. 35 (2008) S 400
Radionuclide metrology using liquid scintillation counting.
R. Broda, P. Cassette, K. Kossert
Metrologia Vol. 44 (2007) S36
Somatostatin receptor scintigraphy using 99mTc-EDDA/HYNIC-TOC in patients with modullary thyroid carcinoma
R. Czepczyński, … , R. Mikołajczak, … et al.
Eur. J. Nucl. Med. Mol. Imaging Vol. 34 (2007) 1635
Radioisotope Centre POLATOM manufacturer of radioactive substances for medicine, science and industry
E. Iller, J. Staniszewska
Analityka : nauka i praktyka Vol. 2 (2007) 38-39
99mTc-EDDA/HYNIC-Octreotate in detection of a typical bronchial carcinoid
A. Hubalewska-Dydejczyk, K. Fross-Baron, F. Golkowski, A. Sowa-Staszczak, R. Mikołajczak, B. Huszno
Exp. Clin. Endocrinol Diabetes Vol. 115 (2007) 47
Radio-guideds Surgery (RGS) with the use of [(99m)Tc-EDDA/HYNIC]octreotate in intra-operative detection of neuroendocrine tumours of gastrointestinal tract
A. Hubalewska-Dydejczyk, … , R. Mikołajczak, … et al.
Eur. J. Nucl. Med. Mol. Imaging Vol. 34 (2007) 1545
Two peptide receptor legands 99mTc-EDDA/HYNIC-Tyr3-octreotide and 99mTc-EDDA/HYNIC-DGlu-Octagastrin for scintigraphy of modullary thyroid carcinoma
J. Kosowicz, R. Mikołajczak, R. Czepczynski, K. Ziemnicka, J. Sowiński
Cancer. Biotherapy Radiophar. Vol. 22, (2007) 613
An Environment-Friendly Method to Prepare Microcrystalline Cellulose
H. Stupińska, … , E. Iller, … et al.
Fib. & Text. Eastern Eur. Vol. 15 (2007) 167-172
Proporties of cellulose derivatives produced from radiation modified cellulose pulps
E. Iller, H. Stupińska, P. Starostka
Radiat. Phys. Chem. Vol. 76 (2007) 1189
Inclusive production of charged pions in p+C collisions at 158-GeV/c beam momentum
C. Alt, … , H. Białkowska, B. Boimska, P. Szymański, W. Trubnikow, J. Zaranek, … et al.
Eur. Phys. J. C Vol. 49 (2007) 897
The IFIN-HH triple coincidence liquid scintillator counter.
A.C. Razdolescu, R. Broda, P. Cassette, B.R.S. Simpson, W.M. VanWyngaardt
Appl. Radiat. Isot. Vol. 64 (2006) 1510-1514
An approach to the preparation of iodine-125 seed-type sources
I. Cieszykowska, A. Piasecki, M. Mielcarski
Nukleonika Vol. 50 (2005) 17
ACTIVATION CROSS SECTIONS FOR REACTIONS INDUCED BY 14 MeV NEUTRONS ON NATURAL TIN AND ENRICHED 112Sn TARGETS WITH REFERENCE TO 111In PRODUCTION VIA RADIOISOTOPE GENERATOR 112Sn(n,2n)111Sn ® 111In
E. Betak, R. Mikołajczak, J. Staniszewska, S. Mikołajewski, E. Rurarz
Radiochim. Acta Vol. 93 (2005) 311
Statistics of the LS-detector in the case of low counting efficiency.
R. Broda, A. Jęczmieniowski
Appl. Radiat. Isot. Vol. 60 (2004) 453
A review of the triple-to-double coincidence ratio (TDCR) method for standardizing radionuclides.
R. Broda
Appl. Radiat. Isot. Vol. 58 (2003) 585
Seed-less iodine-125 ophthalmic applicators
I. Puchalska, M. Mielcarski
Appl. Radiat. Isot. Vol. 58 (2003) 15
The National Standard Unit of Radionuclide Activity and the related standards in Poland.
A. Chyliński, R. Broda, T. Radoszewski
Nukleonika Vol. 48 (2003) 51
Study of influence of the LS-cocktail composition for the standarisation of radionuclides using the TDCR model.
R. Broda, K. Małetka, T. Terlikowska, P. Cassette,
Appl. Radiat. Isot. Vol. 56 (2002) 285-289
Multi-method of standardisation of radionuclides with triangular scheme of disintegration
A. Chyliński, T. Terlikowska-Droździel, T. Radoszewski, R. Broda
Appl. Radiat. Isot. Vol. 56 (2002) 281-284
Rapid production of 18F from 2-fluoroaniline via the 19F(n,2n)18F reaction using 14 MeV neutrons
R. Mikołajczak, J. Staniszewska, S. Mikołajewski, E. Rurarz
Nukleonika Vol. 47 (2002) 13-18
Deposition of Ru-106 and I-125 on silver by internal electrolysis
M. Mielcarski, I. Puchalska
Nukleonika Vol. 47 (2002) 83
A simple computing program for application of the TDCR method to standardisation of pure-beta emitters
R. Broda, P. Cassette, K. Małetka, K. Pochwalski
Appl. Radiat. Isot. Vol. 52 (2000) 673
Analysis of detection-efficiency variation techniques for the implementation of the TDCR method in liquid scintillation counting
P. Cassette, R. Broda, H. Hainos, T. Terlikowska
Appl. Radiat. Isot. Vol. 52 (2000) 643-648
Electrodeposition of 106Ru and 241Am and derived information on preparing sealed radiation sources
E. Molenda, M. Mielcarski
J. Radioanal. Nucl. Chem. Vol. 238 (1998) 159
Phase transition in the ionic conductor Li2UBr6 studied by neutron powder diffraction.
K. Małetka, E. Ressouche, H. Rundlöf, R. Tellgren, R. Delaplane, W. Szczepaniak, M. Zabłocka-Malicka
Solid State Ionics Vol. 106 (1998) 55-69
Inclusion of radionuclides into cathodic composite layers
M. Mielcarski
J. Radioanal. Nucl. Chem. Vol. 205 (1996) 135
Neutron diffraction and electrical conductivity studies of Li2UI6 ionic conductor.
K. Małetka, H. Rundlöf, R. Tellgren, W. Szczepaniak, L. Rycerz,
Solid State Ionics Vol. 90 (1996) 67-74
High temperature phase transition in Na2UI6 by neutron powder diffraction
K. Małetka, A. Murasik, H. Rundlöf, R. Tellgren, W. Szczepaniak,
Solid State Ionics Vol. 76 (1995) 115-120
Electrolytic composite plating as a method of 90Sr fixing for the preparation of radiation sources
M. Mielcarski, M. Poninski, U. Lorens
Appl. Radiat. Isot. Vol. 45 (1994) 429
Ionic conductivity in Na2UI6 .
K. Małetka, A. Murasik, W. Szczepaniak
Nukleonika Vol. 39 (1994) 173-178
Structural and magnetic properties of RMnxGe2 (R = Nd, Sm, Gd, Tb, Dy, Ho, Er) intermetallic compounds
A. Gil, J. Leciejewicz, K. Małetka, A. Szytula
J. Magn. Magn. Mater. Vol. 129 (1994) 155-159
Neutron diffraction study of Ce2RhSi3 , Nd2RhSi3 and Tb2RhSi3
A. Szytuła, J. Leciejewicz, K. Małetka
J. Magn. Magn. Mater. Vol. 118 (1993) 302-306
Structure analysis of Na2UI6 by neutron powder diffraction
K. Małetka, P. Fischer, A. Murasik, W. Szczepaniak
J.Appl.Cryst. Vol. 25B (1992) 1-5
Magnetic ordering in TbNiGe2 and HoNi0.64Ge2 by neutron diffraction
W. Bażela, J. Leciejewicz, K. Małetka, A. Szytuła
J. Magn. Magn. Mater. Vol. 109 (1992) 305-308
Magnetic structure of TbAgSn and HoAgSn
W. Bażela, J. Leciejewicz, K. Małetka, A. Szytuła
J. Magn. Magn. Mater. Vol. 117 (1992) L1-L4
Magnetic properties of Mn6Ni16Si7 and Mn3Cr3Ni16Si7
M. Kolenda, A. Szytuła, J. Leciejewicz, K. Małetka
J. Magn. Magn. Mater. Vol. 96 (1991) 121-124
Neutron Crystallographic Study of Iron substituted YBaCuO
T. Jaworska, A. Szytuła, J. Leciejewicz, H. Ptasiewicz-Bąk, K. Małetka
Supercond. Sci. Technol. Vol. 4 (1991) 55-56
Patenty
Nr prawa ochronnego: Pat. 235218 , Wynalazek: Sposób oddzielania mikroilości skandu od makroilości wapnia.Twórcy: D. Pawlak, W. Wojdowska, L. Parus, R. Mikołajczak, Data przyznania: 2020.07.16
Zgłoszenia patentowe
Zgłoszenie z dnia 12.04.2019 r. Nr: 38405/19/RP/WA/ZBPH/PG „Pochodne inhibitorów PSMA do znakowania 99mTc poprzez HYNIC, zestaw radiofarmaceutyczny, preparaty radiofarmaceutyczne oraz ich zastosowanie w diagnostyce raka prostaty.” US PATENT: 16559014; EUROPEAN PATENT: EP19199838.4; Twórcy: A.E. Sikora, M. Maurin, A.W. Jaroń, J. Pijarowska-Kruszyna, M. Orzełowska, B. Janota, M. Radzik, P. Garnuszek, rok: 2019
Inne osiągniecia
W czerwcu 2020, Pani dr hab. inż. Renata Mikołajczak zostaje powierzone w Komitecie Farmakopei Europejskiej kierownictwo grupą roboczą zajmującą się opracowywaniem monografii dla prekursorów radiofarmaceutyków, Precursors for Radiopharmaceutical Preparations (PRP Working Party).
W marcu 2020, projekt pt. „Zastosowanie terapii tandemowej LutaPol/ItraPol (177Lu/90Y-DOTATATE) jako skutecznego narzędzia w leczeniu nowotworów neuroendokrynnych” otrzyma ponad 16 mln zł wsparcia. Naukowcy z NCBJ zrealizują badania we współpracy z Wojskowym Instytutem Medycznym, Centrum Onkologii – Instytutem MS-C, Świętokrzyskim Centrum Onkologii, Szpitalem Uniwersyteckim w Krakowie oraz Collegium Medicum UJ. LutaPol oraz Itrapol to dwa radiofarmaceutyki opracowane i produkowane w OR POLATOM, które w 2014 roku zostały nagrodzone tytułem „Polski Produkt Przyszłości Jednostki Naukowej”. Ich zastosowanie w terapii tandemowej, czyli łączącej jednoczesne działanie tych dwóch leków o różnej energii promieniowania i różnych zasięgach w tkankach, może pozwolić na leczenie nowotworów endokrynnych, które nie kwalifikują się do leczenia operacyjnego. Warto podkreślić, że NCBJ jest jedynym wnioskodawcą wyróżnionym w konkursie ABM, który nie jest uniwersytetem medycznym lub szpitalem.
The SNMMI 2018 International Best Abstract Award for Poland, presented to Renata Mikolajczak for „Cyclotron production of Sc-44 from natural calcium”, R. Mikołajczak, D. Pawlak, W. Wojdowska, T. Janiak, T. Barcikowski, M. Żółtowska, I. Cieszykowska, J. L. Parus, I. Hajdu, G. Baranyai, V. Forgács, D. Szikra, G. Nagy (nagroda zagraniczna), Society of Nuclear Medicine and Molecular Imaging, SNMMI.
